−740KRW
17.58 BKRW
161.97 MKRW
17.93 M
About PRESTIGE BIOPHARMA
Sector
Industry
CEO
So-Yeon Park
Website
Headquarters
Singapore
Employees (FY)
68
Founded
2005
ISIN
KR8702070002
FIGI
BBG00Y4Y6M38
Prestige BioPharma Ltd. engages in the development and commercialization of biosimilars and antibody therapeutics. The firm develops antibody drugs for solid tumor, pancreatic cancer, and arthritis. Its product portfolio includes Herceptin, Avastin, and Humira biosimilars as well as anti-PAUF and anti-CTHRC1 antibodies. The company was founded in July 2005 and is headquartered in Singapore.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
